• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HTLV-III gag protein is processed in yeast cells by the virus pol-protease.

作者信息

Kramer R A, Schaber M D, Skalka A M, Ganguly K, Wong-Staal F, Reddy E P

出版信息

Science. 1986 Mar 28;231(4745):1580-4. doi: 10.1126/science.2420008.

DOI:10.1126/science.2420008
PMID:2420008
Abstract

The gag-pol gene of HTLV-III (human T-lymphotropic virus), the virus linked to AIDS (acquired immune deficiency syndrome), was expressed in yeast, and processing of the gag precursor into proteins of the same size as those in the virion was observed. Processing of the gag gene in yeast cells mimics the process that naturally occurs in mammalian cells during maturation of virions. Therefore it was possible to perform mutational analysis of the virus genome to localize the gene that codes for the protease function to the amino terminal coding region of the pol gene. Since this region overlaps the gag gene, it is likely that ribosomal frameshifting occurs from gag to pol. Antibodies in all of the AIDS patients' sera tested recognized the yeast synthesized gag proteins, although the sera showed differences in relative reactivity to the individual gag proteins and the precursor. This yeast system should be valuable not only for production of viral proteins for diagnostic or vaccine purposes but also for analysis of the genetics and biochemistry of viral gene functions--parameters that are difficult to study otherwise with this virus.

摘要

相似文献

1
HTLV-III gag protein is processed in yeast cells by the virus pol-protease.
Science. 1986 Mar 28;231(4745):1580-4. doi: 10.1126/science.2420008.
2
Processing of gag precursor polyprotein of human T-cell leukemia virus type I by virus-encoded protease.I型人类T细胞白血病病毒的病毒编码蛋白酶对gag前体多蛋白的加工。
J Virol. 1988 Oct;62(10):3718-28. doi: 10.1128/JVI.62.10.3718-3728.1988.
3
Structural and antigenic characterization of the proteins of human T-cell leukemia viruses and their relationships to the gene products of other retroviruses.人类T细胞白血病病毒蛋白质的结构与抗原特性及其与其他逆转录病毒基因产物的关系。
Princess Takamatsu Symp. 1984;15:147-57.
4
Three novel genes of human T-lymphotropic virus type III: immune reactivity of their products with sera from acquired immune deficiency syndrome patients.人嗜T淋巴细胞病毒III型的三个新基因:其产物与获得性免疫缺陷综合征患者血清的免疫反应性
Proc Natl Acad Sci U S A. 1986 Apr;83(7):2209-13. doi: 10.1073/pnas.83.7.2209.
5
Identification of a protease gene of human T-cell leukemia virus type I (HTLV-I) and its structural comparison.人类嗜T淋巴细胞病毒I型(HTLV-I)蛋白酶基因的鉴定及其结构比较。
Biochem Biophys Res Commun. 1986 Aug 29;139(1):129-35. doi: 10.1016/s0006-291x(86)80089-4.
6
Complete nucleotide sequence of an infectious clone of human T-cell leukemia virus type II: an open reading frame for the protease gene.人T细胞白血病病毒II型感染性克隆的完整核苷酸序列:蛋白酶基因的一个开放阅读框。
Proc Natl Acad Sci U S A. 1985 May;82(10):3101-5. doi: 10.1073/pnas.82.10.3101.
7
Complete nucleotide sequence of the AIDS virus, HTLV-III.艾滋病病毒HTLV-III的完整核苷酸序列。
Nature. 1985;313(6000):277-84. doi: 10.1038/313277a0.
8
Nucleotide sequence analysis of human T-cell leukemia virus type II.人T细胞白血病病毒II型的核苷酸序列分析
Princess Takamatsu Symp. 1984;15:165-75.
9
Human endogenous retroviruslike genome with type C pol sequences and gag sequences related to human T-cell lymphotropic viruses.具有C型pol序列和与人类嗜T细胞病毒相关的gag序列的人类内源性逆转录病毒样基因组。
J Virol. 1987 Dec;61(12):4060-6. doi: 10.1128/JVI.61.12.4060-4066.1987.
10
Human T-cell lymphotropic virus type III (HTLV-III) core antigens: synthesis in Escherichia coli and immunoreactivity with human sera.人类嗜T淋巴细胞病毒III型(HTLV-III)核心抗原:在大肠杆菌中的合成及其与人血清的免疫反应性。
DNA. 1986 Apr;5(2):93-9. doi: 10.1089/dna.1986.5.93.

引用本文的文献

1
Drug Discovery and Exploration of Heterocycles for the Development of Anti-HIV Agents.用于抗HIV药物开发的杂环类药物发现与探索
Infect Disord Drug Targets. 2025;25(3):e18715265290911. doi: 10.2174/0118715265290911240611072422.
2
Darunavir-Resistant HIV-1 Protease Constructs Uphold a Conformational Selection Hypothesis for Drug Resistance.达芦那韦耐药 HIV-1 蛋白酶构建体支持耐药性的构象选择假说。
Viruses. 2020 Nov 8;12(11):1275. doi: 10.3390/v12111275.
3
An Efficient Synthesis of Hydroxyethylene Dipeptide Isosteres: The Core Unit of Potent HIV-1 Protease Inhibitors.
高效合成羟乙烯二肽类似物:强效HIV-1蛋白酶抑制剂的核心单元
J Org Chem. 1991 Nov;56(23):6500-6503. doi: 10.1021/jo00023a009.
4
STEREOCONTROLLED SYNTHESIS OF HIV-l PROTEASE INHIBITORS WITH C-AXIS OF SYMMETRY.具有C对称轴的HIV-1蛋白酶抑制剂的立体控制合成。
Tetrahedron Lett. 1991 Oct 7;32(41):5729-5732. doi: 10.1016/S0040-4039(00)93541-X. Epub 2001 Mar 26.
5
An insight to the molecular interactions of the FDA approved HIV PR drugs against L38L↑N↑L PR mutant.洞察 FDA 批准的 HIV PR 药物与 L38L↑N↑L PR 突变体的分子相互作用。
J Comput Aided Mol Des. 2018 Mar;32(3):459-471. doi: 10.1007/s10822-018-0099-9. Epub 2018 Feb 3.
6
Successes and challenges with retroviral enzymes.逆转录病毒酶的成功与挑战
Postepy Biochem. 2016;62(3):280-285.
7
Approved Antiviral Drugs over the Past 50 Years.过去50年中获批的抗病毒药物。
Clin Microbiol Rev. 2016 Jul;29(3):695-747. doi: 10.1128/CMR.00102-15.
8
Cancer prevention in HIV-infected populations.HIV感染人群的癌症预防
Semin Oncol. 2016 Feb;43(1):173-188. doi: 10.1053/j.seminoncol.2015.09.011. Epub 2015 Sep 8.
9
Transition-state inhibitors of purine salvage and other prospective enzyme targets in malaria.嘌呤补救的过渡态抑制剂和疟疾中的其他潜在酶靶标。
Future Med Chem. 2013 Jul;5(11):1341-60. doi: 10.4155/fmc.13.51.
10
Hydrophobic core flexibility modulates enzyme activity in HIV-1 protease.疏水性核心的柔韧性调节 HIV-1 蛋白酶的酶活性。
J Am Chem Soc. 2012 Mar 7;134(9):4163-8. doi: 10.1021/ja2095766. Epub 2012 Feb 28.